Medtronic, Inc. (MDT) PT Raised to $145 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Google escapes ad tech breakup in third Big Tech antitrust loss for US
Medtronic, Inc. (MDT) PT Raised to $147 at Oppenheimer
May 28, 2021 9:50 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Medtronic, Inc. (NYSE: MDT) to $147.00 (from $134.00) while maintaining an Outperform rating following fourth quarter results.
The analyst commented, "On its F4Q21 call, MDT highlighted continued COVID-19 procedural recovery and solid sales outlook. Key updates: 1) monthly... More
